Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages

Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR) that causes right ventricular failure and death. The early alternative activation of macrophages is a critical event in the development of PVR and PH, but the underlying mechanisms...

Full description

Bibliographic Details
Main Authors: Li Hu, Yanfang Yu, Yueyao Shen, Huijie Huang, Donghai Lin, Kang Wang, Youjia Yu, Kai Li, Yue Cao, Qiang Wang, Xiaoxuan Sun, Zhibing Qiu, Dong Wei, Bin Shen, Jingyu Chen, David Fulton, Yong Ji, Jie Wang, Feng Chen
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231723000393
_version_ 1811154725746245632
author Li Hu
Yanfang Yu
Yueyao Shen
Huijie Huang
Donghai Lin
Kang Wang
Youjia Yu
Kai Li
Yue Cao
Qiang Wang
Xiaoxuan Sun
Zhibing Qiu
Dong Wei
Bin Shen
Jingyu Chen
David Fulton
Yong Ji
Jie Wang
Feng Chen
author_facet Li Hu
Yanfang Yu
Yueyao Shen
Huijie Huang
Donghai Lin
Kang Wang
Youjia Yu
Kai Li
Yue Cao
Qiang Wang
Xiaoxuan Sun
Zhibing Qiu
Dong Wei
Bin Shen
Jingyu Chen
David Fulton
Yong Ji
Jie Wang
Feng Chen
author_sort Li Hu
collection DOAJ
description Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR) that causes right ventricular failure and death. The early alternative activation of macrophages is a critical event in the development of PVR and PH, but the underlying mechanisms remain elusive. Previously we have shown that N6-methyladenosine (m6A) modifications of RNA contribute to phenotypic switching of pulmonary artery smooth muscle cells and PH. In the current study, we identify Ythdf2, an m6A reader, as an important regulator of pulmonary inflammation and redox regulation in PH. In a mouse model of PH, the protein expression of Ythdf2 was increased in alveolar macrophages (AMs) during the early stages of hypoxia. Mice with a myeloid specific knockout of Ythdf2 (Ythdf2Lyz2 Cre) were protected from PH with attenuated right ventricular hypertrophy and PVR compared to control mice and this was accompanied by decreased macrophage polarization and oxidative stress. In the absence of Ythdf2, heme oxygenase 1 (Hmox1) mRNA and protein expression were significantly elevated in hypoxic AMs. Mechanistically, Ythdf2 promoted the degradation of Hmox1 mRNA in a m6A dependent manner. Furthermore, an inhibitor of Hmox1 promoted macrophage alternative activation, and reversed the protection from PH seen in Ythdf2Lyz2 Cre mice under hypoxic exposure. Together, our data reveal a novel mechanism linking m6A RNA modification with changes in macrophage phenotype, inflammation and oxidative stress in PH, and identify Hmox1 as a downstream target of Ythdf2, suggesting that Ythdf2 may be a therapeutic target in PH.
first_indexed 2024-04-10T04:21:53Z
format Article
id doaj.art-91d134e9a9a54851932ce108a81529bf
institution Directory Open Access Journal
issn 2213-2317
language English
last_indexed 2024-04-10T04:21:53Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Redox Biology
spelling doaj.art-91d134e9a9a54851932ce108a81529bf2023-03-11T04:19:38ZengElsevierRedox Biology2213-23172023-05-0161102638Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophagesLi Hu0Yanfang Yu1Yueyao Shen2Huijie Huang3Donghai Lin4Kang Wang5Youjia Yu6Kai Li7Yue Cao8Qiang Wang9Xiaoxuan Sun10Zhibing Qiu11Dong Wei12Bin Shen13Jingyu Chen14David Fulton15Yong Ji16Jie Wang17Feng Chen18Department of Forensic Medicine, Nanjing Medical University, Nanjing, China; Gusu School, Nanjing Medical University, Suzhou, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Rheumatology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, ChinaDepartment of Thoracic and Cardiovascular Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, ChinaWuxi Lung Transplantation Center, Wuxi People's Hospital Affiliated with Nanjing Medical University, Wuxi, ChinaState Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, ChinaWuxi Lung Transplantation Center, Wuxi People's Hospital Affiliated with Nanjing Medical University, Wuxi, ChinaVascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USAKey Laboratory of Cardiovascular and Cerebrovascular Medicine, Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, ChinaDepartment of Forensic Medicine, Nanjing Medical University, Nanjing, China; Corresponding author.Department of Forensic Medicine, Nanjing Medical University, Nanjing, China; Gusu School, Nanjing Medical University, Suzhou, China; Vascular Biology Center, Medical College of Georgia at Augusta University, Augusta, GA, USA; Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, Nanjing, China; Corresponding author. Key Laboratory of Targeted Intervention of Cardiovascular Disease, Collaborative Innovation Center for Cardiovascular Disease Translational Medicine, Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing, Jiangsu 210029, China.Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR) that causes right ventricular failure and death. The early alternative activation of macrophages is a critical event in the development of PVR and PH, but the underlying mechanisms remain elusive. Previously we have shown that N6-methyladenosine (m6A) modifications of RNA contribute to phenotypic switching of pulmonary artery smooth muscle cells and PH. In the current study, we identify Ythdf2, an m6A reader, as an important regulator of pulmonary inflammation and redox regulation in PH. In a mouse model of PH, the protein expression of Ythdf2 was increased in alveolar macrophages (AMs) during the early stages of hypoxia. Mice with a myeloid specific knockout of Ythdf2 (Ythdf2Lyz2 Cre) were protected from PH with attenuated right ventricular hypertrophy and PVR compared to control mice and this was accompanied by decreased macrophage polarization and oxidative stress. In the absence of Ythdf2, heme oxygenase 1 (Hmox1) mRNA and protein expression were significantly elevated in hypoxic AMs. Mechanistically, Ythdf2 promoted the degradation of Hmox1 mRNA in a m6A dependent manner. Furthermore, an inhibitor of Hmox1 promoted macrophage alternative activation, and reversed the protection from PH seen in Ythdf2Lyz2 Cre mice under hypoxic exposure. Together, our data reveal a novel mechanism linking m6A RNA modification with changes in macrophage phenotype, inflammation and oxidative stress in PH, and identify Hmox1 as a downstream target of Ythdf2, suggesting that Ythdf2 may be a therapeutic target in PH.http://www.sciencedirect.com/science/article/pii/S2213231723000393Alveolar macrophagesOxidant stressInflammationYthdf2Heme oxygenase 1Pulmonary hypertension
spellingShingle Li Hu
Yanfang Yu
Yueyao Shen
Huijie Huang
Donghai Lin
Kang Wang
Youjia Yu
Kai Li
Yue Cao
Qiang Wang
Xiaoxuan Sun
Zhibing Qiu
Dong Wei
Bin Shen
Jingyu Chen
David Fulton
Yong Ji
Jie Wang
Feng Chen
Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
Redox Biology
Alveolar macrophages
Oxidant stress
Inflammation
Ythdf2
Heme oxygenase 1
Pulmonary hypertension
title Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
title_full Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
title_fullStr Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
title_full_unstemmed Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
title_short Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages
title_sort ythdf2 promotes pulmonary hypertension by suppressing hmox1 dependent anti inflammatory and antioxidant function in alveolar macrophages
topic Alveolar macrophages
Oxidant stress
Inflammation
Ythdf2
Heme oxygenase 1
Pulmonary hypertension
url http://www.sciencedirect.com/science/article/pii/S2213231723000393
work_keys_str_mv AT lihu ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT yanfangyu ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT yueyaoshen ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT huijiehuang ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT donghailin ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT kangwang ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT youjiayu ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT kaili ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT yuecao ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT qiangwang ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT xiaoxuansun ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT zhibingqiu ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT dongwei ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT binshen ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT jingyuchen ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT davidfulton ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT yongji ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT jiewang ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages
AT fengchen ythdf2promotespulmonaryhypertensionbysuppressinghmox1dependentantiinflammatoryandantioxidantfunctioninalveolarmacrophages